<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03658941</url>
  </required_header>
  <id_info>
    <org_study_id>KB/106/2018</org_study_id>
    <nct_id>NCT03658941</nct_id>
  </id_info>
  <brief_title>Dural Tenting Sutures in Neurosurgery - is it Necessary?</brief_title>
  <official_title>Prophylactic Use of Dural Tenting Sutures in Elective Craniotomies - is it Necessary? A Multicentre Randomised Study.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Medical University of Warsaw</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Medical University of Warsaw</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study evaluates the necessity of dural tenting sutures in craniotomies. The sutures
      elevate the dura, a layer between the brain and skull. Supposedly, by doing so, they prevent
      blood collecting between dura mater and the skull. These blood collections, called epidural
      hematomas, contributed greatly to postoperative mortality in the early days of neurosurgery.
      There have been several reports questioning the ongoing need for them in neurosurgery, thanks
      to modern hemostatic techniques. Moreover, it has been published in the literature, and is a
      common knowledge as well, that some neurosurgeons do not use these sutures at all, and do not
      have worse outcomes than their colleagues.

      In this study, half of the randomly assigned participants will undergo craniotomy without
      dural tenting sutures and will be considered an intervention group. The other half will
      undergo craniotomy with these sutures.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      In the early days of neurosurgery, epidural hemorrhages (EDH) contributed to a high mortality
      rate after craniotomies. Almost a century ago Walter Dandy reported dural tenting sutures as
      an effective way of preventing postoperative EDH. Over time, his technique gained in
      popularity and significance to finally become a neurosurgical standard.

      Yet, there have been several retrospective reports questioning the ongoing need for dural
      tenting sutures. Dandy's explanation that the hemostasis under hypotensive conditions is
      deceiving and eventually causes EDH may be obsolete. These days, proper intra- and
      postoperative care, including maintenance of normovolemia and normotension and the use of
      modern hemostatic agents, may be enough for effective hemostasis. Evading of this suturing
      technique by some surgeons supports this argument even further.

      Thus, there is a fundamental need to evaluate the necessity of dural tenting sutures in an
      unbiased, evidence-based manner.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">September 7, 2018</start_date>
  <completion_date type="Anticipated">April 1, 2022</completion_date>
  <primary_completion_date type="Anticipated">September 1, 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>We plan to include 2000 subjects in this study. Each subject will undergo a craniotomy for unrelated pathology. Each of the subjects will be assigned in random order to an intervention or control group. The intervention group will not have dural tenting sutures during closure of their craniotomy while the control group will have at least three.
Both groups will be followed radiologically and clinically, in the exact same manner.</intervention_model_description>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Triple (Participant, Investigator, Outcomes Assessor)</masking>
    <masking_description>Due to the nature of the surgical procedures, the surgeon and the rest of the OR medical team will be aware of the current subject's allocation. However, in each case, the specific OR team aware of the subject's allocation will be different from the investigators performing further evaluation of the given subject. The following study procedures will be in place to ensure double-blind administration of the study.
Access to the randomization code will be strictly controlled.
The surgeon will receive information on subject's allocation after commencing the surgery.
The study blind will be broken:
During interim monitoring, after recruiting the first 100 patients.
On completion of the clinical study and after the study database has been locked.
When patients' safety requires access to allocation data.</masking_description>
  </study_design_info>
  <primary_outcome>
    <measure>Reoperation due to epidural hematoma</measure>
    <time_frame>During hospitalization for the surgery, approximately 2 days postoperatively</time_frame>
    <description>Surgery for the postoperative extradural hematoma</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Postoperative 30-day mortality</measure>
    <time_frame>30-day postoperatively</time_frame>
    <description>The data to measure postoperative 30-day mortality will be obtained from a national database 30 days after the recruitment of all participants has been completed.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Postoperative 30-day readmission to a neurosurgical or neurological department</measure>
    <time_frame>30-day postoperatively</time_frame>
    <description>The data required to evaluate readmission rates will be obtained from the hospital databases.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>New neurologic deficit or deterioration of a previous one</measure>
    <time_frame>during hospitalisation, as evaluated 5-7 days postoperatively, or earlier if the patient is discharged before the fifth postsurgical day.</time_frame>
    <description>New neurologic deficit or deterioration of a preoperative deficit, as evaluated on postoperative day 5-7.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Cerebrospinal fluid leak requiring treatment.</measure>
    <time_frame>during hospitalisation, as evaluated 5-7 days postoperatively, or earlier if the patient is discharged before the fifth postsurgical day.</time_frame>
    <description>Presence of a cerebrospinal fluid leak requiring treatment.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Deterioration of postoperative headaches over 5 Numerical Rating Scale</measure>
    <time_frame>during hospitalisation, as evaluated 5-7 days postoperatively, or earlier if the patient is discharged before the fifth postsurgical day.</time_frame>
    <description>The Numeric Rating Scale is an 11-point scale for patient self-reporting of pain. It ranges from 0 (no pain) to 10 (the worst imaginable pain). There are no subscales. Higher values indicate more pain and, therefore, represent undesirable outcome.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Epidural collection thickness over 3 mm measured radiographically</measure>
    <time_frame>During hospitalization, approximately 1-3 days postoperatively</time_frame>
    <description>Extradural collection thickness measured in postoperative Computed Tomography by two independent radiologists</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Midline shift over 5 mm</measure>
    <time_frame>During hospitalization, approximately 1-3 days postoperatively</time_frame>
    <description>Extradural collection thickness measured in postoperative Computed Tomography by two independent radiologists</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">2000</enrollment>
  <condition>Epidural Hematoma</condition>
  <arm_group>
    <arm_group_label>No dural tenting sutures</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>No dural tenting techniques</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Dural tenting sutures</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Dural tenting techniques</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>No dural tenting techniques</intervention_name>
    <description>Not applying dural tenting sutures during closure of a craniotomy</description>
    <arm_group_label>No dural tenting sutures</arm_group_label>
    <other_name>tack-up sutures</other_name>
    <other_name>hitch-up stitches</other_name>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Dural tenting techniques</intervention_name>
    <description>Applying at least 3 dural tenting sutures during closure of a craniotomy</description>
    <arm_group_label>Dural tenting sutures</arm_group_label>
    <other_name>tack-up sutures</other_name>
    <other_name>hitch-up stitches</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  male or female over 18 and under 75 years old

          -  qualified for an elective supratentorial craniotomy with a diameter of at least 3 cm

          -  Glasgow Coma Scale 15 preoperatively

          -  Modified Rankin Scale 0, 1 or 2 preoperatively

        Exclusion Criteria:

          -  Coagulation abnormalities before the surgery

          -  Revision craniotomy

          -  Skull base surgery
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Łukasz Przepiórka</last_name>
    <role>Principal Investigator</role>
    <affiliation>Department of Neurosurgery, Medical University of Warsaw</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Przemysław Kunert, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Department of Neurosurgery, Medical University of Warsaw</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Przemysław Kunert, MD, PhD</last_name>
    <phone>+48 22 599 25 75</phone>
    <email>przemyslaw.kunert@wum.edu.pl</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Łukasz Przepiórka</last_name>
    <email>przepiorka@mp.pl</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Department of Neurosurgery, 10th Military Research Hospital and Polyclinic</name>
      <address>
        <city>Bydgoszcz</city>
        <state>Kuyavian-pomeranian</state>
        <zip>85-681</zip>
        <country>Poland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Kamil Krystkiewicz, MD</last_name>
      <phone>261 417 093</phone>
    </contact>
    <investigator>
      <last_name>Marek Harat, MD, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>5 Neurosurgery and Pediatric Neurosurgery Department in Lublin, Medical University of Lublin</name>
      <address>
        <city>Lublin</city>
        <state>Lubelskie</state>
        <zip>20-954</zip>
        <country>Poland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Radosław Rola, MD, PhD</last_name>
      <phone>+48 81 724 41 76</phone>
    </contact>
    <investigator>
      <last_name>Dariusz Szczepanek, MD, PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Tomasz Trojanowski, MD, PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Radosław Rola, MD, PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Department of Neurosurgery, Medical University of Warsaw</name>
      <address>
        <city>Warsaw</city>
        <state>Mazovian</state>
        <zip>02-097</zip>
        <country>Poland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Łukasz Przepiórka</last_name>
      <email>przepiorka@mp.pl</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Department of Neurosurgery and Pediatric Neurosurgery, Pomeranian Medical University</name>
      <address>
        <city>Szczecin</city>
        <state>West Pomeranian</state>
        <zip>71-252</zip>
        <country>Poland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Leszek Sagan, MD, PhD</last_name>
      <phone>91 425 35 61</phone>
    </contact>
    <investigator>
      <last_name>Leszek Sagan, MD, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Department of Neurosurgery and Oncology of Central Nervous System, Barlicki University Hospital, Medical University of Lodz</name>
      <address>
        <city>Łódź</city>
        <state>Łódzkie</state>
        <zip>90-153</zip>
        <country>Poland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jan Fortuniak, MD</last_name>
      <phone>+48 42 677 67 82</phone>
    </contact>
    <investigator>
      <last_name>Jan Fortuniak, MD, PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Karol Wiśniewski, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Dariusz Jaskólski, MD, PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Department of Neurosurgery, Medical University of Silesia, Regional Hospital, Sosnowiec</name>
      <address>
        <city>Sosnowiec</city>
        <state>Śląskie</state>
        <zip>41-200</zip>
        <country>Poland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Patrycja Larysz, MD, PhD</last_name>
      <phone>+48 32 368 25 51</phone>
    </contact>
    <investigator>
      <last_name>Patrycja Larysz, MD, PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Piotr Ładziński, MD, PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Poland</country>
  </location_countries>
  <link>
    <url>http://rctszwydandy.wum.edu.pl/en</url>
    <description>Website of the clinical trial</description>
  </link>
  <reference>
    <citation>Swayne OB, Horner BM, Dorward NL. The hitch stitch: an obsolete neurosurgical technique? Br J Neurosurg. 2002 Dec;16(6):541-4; discussion 544.</citation>
    <PMID>12617233</PMID>
  </reference>
  <reference>
    <citation>Winston KR. Efficacy of dural tenting sutures. J Neurosurg. 1999 Aug;91(2):180-4.</citation>
    <PMID>10433304</PMID>
  </reference>
  <reference>
    <citation>Winston KR. Dural tenting sutures in pediatric neurosurgery. Pediatr Neurosurg. 1998 May;28(5):230-5.</citation>
    <PMID>9732254</PMID>
  </reference>
  <reference>
    <citation>Wadanamby, S. et al., (2016). Is dural hitching necessary to prevent post-operative extradural haemorrhage in craniotomies and craniectomies. Sri Lanka Journal of Surgery. 34(2), pp.11-17. DOI: http://doi.org/10.4038/sljs.v34i2.8262</citation>
  </reference>
  <verification_date>January 2019</verification_date>
  <study_first_submitted>August 31, 2018</study_first_submitted>
  <study_first_submitted_qc>August 31, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">September 6, 2018</study_first_posted>
  <last_update_submitted>January 20, 2020</last_update_submitted>
  <last_update_submitted_qc>January 20, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">January 23, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>craniotomy</keyword>
  <keyword>dural tenting suture</keyword>
  <keyword>epidural hematoma</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hematoma, Epidural, Cranial</mesh_term>
    <mesh_term>Hematoma</mesh_term>
    <mesh_term>Hematoma, Epidural, Spinal</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
    <ipd_description>The trial protocol, full study report, anonymised participant-level dataset and statistical code for generating the results will be made publicly available if all investigators agree to share the data.</ipd_description>
  </patient_data>
  <provided_document_section>
    <provided_document>
      <document_type>Statistical Analysis Plan</document_type>
      <document_has_protocol>No</document_has_protocol>
      <document_has_icf>No</document_has_icf>
      <document_has_sap>Yes</document_has_sap>
      <document_date>January 14, 2020</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/41/NCT03658941/SAP_006.pdf</document_url>
    </provided_document>
    <provided_document>
      <document_type>Study Protocol</document_type>
      <document_has_protocol>Yes</document_has_protocol>
      <document_has_icf>No</document_has_icf>
      <document_has_sap>No</document_has_sap>
      <document_date>January 14, 2020</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/41/NCT03658941/Prot_007.pdf</document_url>
    </provided_document>
  </provided_document_section>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

